REBECCA WALKER: Open Payments
NPI 1336797018 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 35 payments from 14 companies in 2025. Trend: 2023 $433 · 2024 $595 · 2025 $651
Food & beverage: $613Education: $39
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $122 |
| PFIZER INC. | 7 | $111 |
| Novo Nordisk Inc | 6 | $98 |
| Astellas Pharma US Inc | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Lundbeck LLC | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Amgen Inc. | 2 | $32 |
| CSL Behring | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: QULIPTA, ELIQUIS, Veozah, Ozempic, REXULTI, CAPLYTA, EVENITY, NURTEC ODT.
Industry payments across IA — which companies pay providers there.
